Epidemiology of hypospadias in China: A nationwide surveillance‐based study, 2010–2020
Andrology · 2026-03 · 14 (3) · 880-889
DOI: 10.1111/andr.70090 ↗At a glance
Journal article in Andrology, published online on 2025-06-28. Written by Chen Zhiyu and 7 co-authors. Institution: National Center for Birth Defects Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. Major MEDLINE topics: Hypospadias. Cited 7 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Health Commission of the People's Republic of China.
Abstract (original language)
Background
The prevalence of hypospadias varied internationally. However, epidemiological data on hypospadias in contemporary China remain limited.
Objectives
We aim to examine the epidemiological characteristics of hypospadias in Chinese population. Materials and methods We performed a prevalence analysis using data from the Chinese Birth Defects Monitoring Network from 2010 to 2020. We analyzed the prevalence of overall, isolated, and associated hypospadias by birth year, maternal age, maternal residence, and geographic region. We used Poisson regression with adjusted prevalence rate ratios for assessing the impact of demographic characteristics and Joinpoint regression for analyzing temporal trends.
Results
A total of 11,782 hypospadias cases were identified among 11,575,036 male births with a prevalence of 10.18 per 10,000 male births. Of these, 9700 (82.3%) were isolated and 2082 (17.7%) were associated hypospadias. Of these cases, 639 (5.4%) were classified as anterior hypospadias, 1052 (8.9%) as middle hypospadias, 413 (3.5%) as proximal hypospadias, and 9678 (82.1%) as unspecified hypospadias, based on their severity. The prevalence of overall, isolated, and associated hypospadias increased significantly over the study period. Prevalence also varied significantly by maternal residence, maternal age, and geographical region. Infants with associated hypospadias experienced a significant higher risk of perinatal death. The most frequent associated anomalies involved the cardiovascular, genitourinary, and musculoskeletal systems. Discussion and conclusion This study provides contemporary national data on the epidemiology of hypospadias in China. The observed increasing prevalence and variations by severity underscore the need for further etiological, epidemiological, and clinical research.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- National Center for Birth Defects Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
- The Joint Laboratory for Pulmonary Development and Related Diseases, West China Institute of Women and Children's Health, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.
- NHC Key Laboratory of Chronobology, Sichuan University, Chengdu, Sichuan, China.
- Med-X Center for Informatics, Sichuan University, Chengdu, Sichuan, China.
ORCID profiles: Li Wenyan
Funding
- National Health Commission of the People's Republic of China
Cite
APA
Zhiyu, C., Yuyang, G., Wenli, X., Wenyan, L., Zhen, L., Jiayuan, Z., Jun, Z., & Li, D. (2026). Epidemiology of hypospadias in China: A nationwide surveillance‐based study, 2010–2020. Andrology, 14(3), 880-889. https://doi.org/10.1111/andr.70090
Vancouver
Zhiyu C, Yuyang G, Wenli X, Wenyan L, Zhen L, Jiayuan Z, et al. Epidemiology of hypospadias in China: A nationwide surveillance‐based study, 2010–2020. Andrology. 2026;14(3):880-889. doi:10.1111/andr.70090
BibTeX
@article{Zhiyu2026,
author = {Zhiyu, Chen and Yuyang, Gao and Wenli, Xu and Wenyan, Li and Zhen, Liu and Jiayuan, Zhou and Jun, Zhu and Li, Dai},
title = {Epidemiology of hypospadias in China: A nationwide surveillance‐based study, 2010–2020},
journal = {Andrology},
year = {2026},
volume = {14},
number = {3},
pages = {880--889},
doi = {10.1111/andr.70090}
}
EUVIMED